Northwest Financial Advisors Royalty Pharma PLC Transaction History
Northwest Financial Advisors
- $126 Billion
- Q3 2024
A detailed history of Northwest Financial Advisors transactions in Royalty Pharma PLC stock. As of the latest transaction made, Northwest Financial Advisors holds 120 shares of RPRX stock, worth $3,538. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120
Previous 126
4.76%
Holding current value
$3,538
Previous $3.32 Million
2.2%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RPRX
# of Institutions
412Shares Held
283MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.21 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$1.11 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$679 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$475 Million0.35% of portfolio
-
Viking Global Investors LP12.1MShares$357 Million1.32% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $12.9B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...